Mar 5 2010
Cymetrix Board Member Joe Sullivan was recognized by the Forum for Corporate Directors as a 2010 Director of the Year Honoree. He was recognized in the category of Corporate Growth and Development for playing a significant role in enhancing the growth and operations of the companies he serves.
Sullivan has served on the board of Cymetrix, Inc., an industry leader providing hospitals and health care networks with adaptive revenue cycle management solutions, since 2006. In addition to Cymetrix, Sullivan is also a board member for Amylin Pharmaceuticals, Inc., AutoGenomics, Inc., HCP, Inc., Maguire Properties, Inc., the University of California Los Angeles Health System, and Rand Health.
"We are proud and fortunate to have Joe on our board of directors and congratulate him on being recognized for his contributions to Cymetrix and the other companies where he holds a board position," said Michael Halberda, president and CEO of Cymetrix. "This award is a confirmation by his peers of what we have known for years – that Joe is committed to providing strategies to build long term shareholder value while maintaining corporate governance integrity."
"We are pleased to recognize Sullivan as a 2010 Director of the Year Honoree," said John Della Grotta, Chair of the Forum for Corporate Directors and a Partner of Paul Hastings. "He has made a positive difference in Cymetrix and the other companies that he serves, discharging his responsibilities in a practical, creative and diligent manner for all shareholders, all within the framework of the highest standards of corporate governance."
According to Sullivan, Cymetrix has distinguished itself by establishing a unique financial model for Healthcare Comprehensive Revenue Cycle Management. Cymetrix transforms financially challenged healthcare systems into profitable ones quickly, which is very important in today's economic climate.
"I am very pleased and honored to be selected as a 2010 Director of the Year Honoree," said Sullivan. "This distinction also reflects favorably on the companies with whom I have the pleasure to work and assist in their development. Cymetrix's future is bright and I look forward to continuing to serve them in an advisory capacity."